POET Technologies Completes US$25 Million Registered Direct Offering

In This Article:

POET Technologies Inc.
POET Technologies Inc.

TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Corporation") (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, is pleased to announce that it has completed its previously announced registered direct offering with a single institutional investor that qualifies as an "accredited investor" under National Instrument 45-106 – Prospectus Exemptions of the Canadian Securities Administrators. The Corporation issued 5,555,556 common shares (the "Common Shares") and a warrant exercisable to acquire up to 2,777,778 Common Shares (the "Warrants") to the investor for aggregate gross proceeds of US$25,000,002 (the “Offering”). The combined price of one Common Share and accompanying Warrant in respect of one-half of one Common Share was US$4.50 (or approximately C$6.29). The exercise price of the Warrant is US$6.00 (or approximately C$8.39) per Common Share, and the Warrant is exercisable for a period of five years from the date of issuance.

The Corporation intends to use the net proceeds of the Offering for working capital related to its recently announced intention to expand assembly operations into Malaysia and for other corporate purposes. No commission or finder's fee was paid by the Corporation, and no underwriter or sales agent was engaged by the Corporation in connection with the Offering.

The Offering is being made pursuant to a prospectus supplement dated December 3, 2024 (the "Prospectus Supplement") to the short form base shelf prospectus (the "Base Shelf Prospectus") of the Corporation dated September 6, 2024 filed with the securities regulatory authorities in each of the provinces and territories of Canada, as well as with the U.S. Securities and Exchange Commission as part of the Corporation’s U.S. registration statement on Form F-10 ("Form F-10") (Registration No. 333-280553) under the U.S.-Canada Multijurisdictional Disclosure System and General Instruction II.L, which included the Prospectus Supplement with such additions thereto and deletions therefrom as may be permitted or required by Form F-10. Copies of the Prospectus Supplement, including the Base Shelf Prospectus, are available on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov.

The Offering remains subject to the final acceptance of the TSX Venture Exchange (the "Exchange").